These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 26732686

  • 21. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women.
    Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ.
    Circulation; 2004 May 11; 109(18):2191-6. PubMed ID: 15123530
    [Abstract] [Full Text] [Related]

  • 22. Impact of hormone replacement on myocardial fatty acid metabolism: potential role of estrogen.
    Herrero P, Soto PF, Dence CS, Kisrieva-Ware Z, Delano DA, Peterson LR, Gropler RJ.
    J Nucl Cardiol; 2005 May 11; 12(5):574-81. PubMed ID: 16171718
    [Abstract] [Full Text] [Related]

  • 23. Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography.
    Hicks RJ, Herman WH, Kalff V, Molina E, Wolfe ER, Hutchins G, Schwaiger M.
    J Am Coll Cardiol; 1991 Jul 11; 18(1):101-11. PubMed ID: 2050912
    [Abstract] [Full Text] [Related]

  • 24. Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine.
    Chen WJY, Diamant M, de Boer K, Harms HJ, Robbers LFHJ, van Rossum AC, Kramer MHH, Lammertsma AA, Knaapen P.
    Cardiovasc Diabetol; 2017 May 19; 16(1):67. PubMed ID: 28526033
    [Abstract] [Full Text] [Related]

  • 25. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus.
    Herrero P, Peterson LR, McGill JB, Matthew S, Lesniak D, Dence C, Gropler RJ.
    J Am Coll Cardiol; 2006 Feb 07; 47(3):598-604. PubMed ID: 16458143
    [Abstract] [Full Text] [Related]

  • 26. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
    Visser FC.
    Coron Artery Dis; 2001 Feb 07; 12 Suppl 1():S12-8. PubMed ID: 11286301
    [Abstract] [Full Text] [Related]

  • 27. Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans.
    Bucci M, Borra R, Någren K, Pärkkä JP, Del Ry S, Maggio R, Tuunanen H, Viljanen T, Cabiati M, Rigazio S, Taittonen M, Pagotto U, Parkkola R, Opie LH, Nuutila P, Knuuti J, Iozzo P.
    Cardiovasc Ther; 2012 Dec 07; 30(6):333-41. PubMed ID: 21884010
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The effect of insulin on net lipid oxidation predicts worsening of insulin resistance and development of type 2 diabetes mellitus.
    Koska J, Ortega E, Bogardus C, Krakoff J, Bunt JC.
    Am J Physiol Endocrinol Metab; 2007 Jul 07; 293(1):E264-9. PubMed ID: 17616607
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A novel partial fatty acid oxidation inhibitor decreases myocardial oxygen consumption and improves cardiac efficiency in demand-induced ischemic heart.
    Wu L, Belardinelli L, Fraser H.
    J Cardiovasc Pharmacol; 2008 Apr 07; 51(4):372-9. PubMed ID: 18427280
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Comparison of fatty acid tracers FTHA and BMIPP during myocardial ischemia and hypoxia.
    Renstrom B, Rommelfanger S, Stone CK, DeGrado TR, Carlson KJ, Scarbrough E, Nickles RJ, Liedtke AJ, Holden JE.
    J Nucl Med; 1998 Oct 07; 39(10):1684-9. PubMed ID: 9776269
    [Abstract] [Full Text] [Related]

  • 37. Dysregulation of muscle fatty acid metabolism in type 2 diabetes is independent of malonyl-CoA.
    Bell JA, Volpi E, Fujita S, Cadenas JG, Rasmussen BB.
    Diabetologia; 2006 Sep 07; 49(9):2144-52. PubMed ID: 16868746
    [Abstract] [Full Text] [Related]

  • 38. Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging.
    Rijzewijk LJ, van der Meer RW, Lamb HJ, de Jong HW, Lubberink M, Romijn JA, Bax JJ, de Roos A, Twisk JW, Heine RJ, Lammertsma AA, Smit JW, Diamant M.
    J Am Coll Cardiol; 2009 Oct 13; 54(16):1524-32. PubMed ID: 19815124
    [Abstract] [Full Text] [Related]

  • 39. Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats.
    Ménard SL, Croteau E, Sarrhini O, Gélinas R, Brassard P, Ouellet R, Bentourkia M, van Lier JE, Des Rosiers C, Lecomte R, Carpentier AC.
    Am J Physiol Endocrinol Metab; 2010 May 13; 298(5):E1049-57. PubMed ID: 20159856
    [Abstract] [Full Text] [Related]

  • 40. Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease.
    Stanley AW, Moraski RE, Russell RO, Rogers WJ, Mantle JA, Kreisberg RA, McDaniel HG, Rackley CE.
    Am J Cardiol; 1975 Dec 13; 36(7):929-37. PubMed ID: 1199950
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.